Drug information for CLADRIBINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 1MG/ML Prescription AP  CLADRIBINE Cladribine ONCO THERAPIES LTD 200510
INJECTABLE; INJECTION 1MG/ML Prescription AP  CLADRIBINE Cladribine BEDFORD 75405
2004-06-01 Letter
2003-08-04 Review
2000-02-28 Letter
INJECTABLE; INJECTION 1MG/ML Prescription AP  CLADRIBINE Cladribine APP PHARMS 76571

Drug Adverse Effects information for CLADRIBINE

Role code Indications Reaction # Reports
PS B-CELL LYMPHOMA HEPATITIS B 2
PS HAIRY CELL LEUKAEMIA ACUTE MYELOID LEUKAEMIA 1
PS HAIRY CELL LEUKAEMIA ASPERGILLOSIS 1
PS HAIRY CELL LEUKAEMIA BONE MARROW FAILURE 1
PS HAIRY CELL LEUKAEMIA DRUG INTOLERANCE 1
PS HAIRY CELL LEUKAEMIA HAIRY CELL LEUKAEMIA 4
PS HAIRY CELL LEUKAEMIA INCORRECT ROUTE OF DRUG ADMINISTRATION 1
PS HAIRY CELL LEUKAEMIA LUNG CANCER METASTATIC 2
PS HAIRY CELL LEUKAEMIA NON-HODGKIN'S LYMPHOMA 1
PS HAIRY CELL LEUKAEMIA PANCREATIC CARCINOMA 2
PS MULTIPLE SCLEROSIS EVENTRATION PROCEDURE 2
PS MULTIPLE SCLEROSIS THYROIDITIS 4
PS WALDENSTROM'S MACROGLOBULINAEMIA BRONCHOPULMONARY ASPERGILLOSIS 6
PS WALDENSTROM'S MACROGLOBULINAEMIA EYE INFECTION TOXOPLASMAL 6
PS WALDENSTROM'S MACROGLOBULINAEMIA HERPES ZOSTER 6
PS WALDENSTROM'S MACROGLOBULINAEMIA LEUKOENCEPHALOPATHY 3
PS WALDENSTROM'S MACROGLOBULINAEMIA MYELODYSPLASTIC SYNDROME 6
PS WALDENSTROM'S MACROGLOBULINAEMIA PNEUMONIA 6
PS WALDENSTROM'S MACROGLOBULINAEMIA PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3
SS ACUTE MONOCYTIC LEUKAEMIA ACUTE MONOCYTIC LEUKAEMIA 16
SS ANTIFUNGAL PROPHYLAXIS ADENOVIRAL HAEMORRHAGIC CYSTITIS 2
SS ANTIFUNGAL PROPHYLAXIS MANTLE CELL LYMPHOMA 2
SS CHRONIC LYMPHOCYTIC LEUKAEMIA MYOSITIS 6
SS CHRONIC LYMPHOCYTIC LEUKAEMIA RICHTER'S SYNDROME 3
SS HAIRY CELL LEUKAEMIA DRUG ERUPTION 1
SS HYPERTENSION ADENOVIRAL HAEMORRHAGIC CYSTITIS 2
SS HYPERTENSION MANTLE CELL LYMPHOMA 2
SS HYPERURICAEMIA ADENOVIRAL HAEMORRHAGIC CYSTITIS 2
SS HYPERURICAEMIA MANTLE CELL LYMPHOMA 2
SS LANGERHANS' CELL HISTIOCYTOSIS ASPERGILLOSIS 15
SS LANGERHANS' CELL HISTIOCYTOSIS OFF LABEL USE 5
SS LANGERHANS' CELL HISTIOCYTOSIS PANCYTOPENIA 59
SS LANGERHANS' CELL HISTIOCYTOSIS PNEUMATOSIS INTESTINALIS 15
SS LANGERHANS' CELL HISTIOCYTOSIS SEPSIS 59
SS LANGERHANS' CELL HISTIOCYTOSIS TOXICITY TO VARIOUS AGENTS 14
SS LEUKAEMIA EMBOLISM 6
SS LEUKAEMIA PULMONARY HAEMORRHAGE 6
SS LEUKAEMIA THROMBOCYTOPENIA 6
SS LYMPHOMA EMBOLISM 6
SS LYMPHOMA PULMONARY HAEMORRHAGE 6
SS LYMPHOMA THROMBOCYTOPENIA 6
SS MANTLE CELL LYMPHOMA ADENOVIRAL HAEMORRHAGIC CYSTITIS 10
SS MANTLE CELL LYMPHOMA MANTLE CELL LYMPHOMA 10
SS MULTIPLE SCLEROSIS EVENTRATION PROCEDURE 2
SS MULTIPLE SCLEROSIS THYROIDITIS 4
SS OEDEMA ADENOVIRAL HAEMORRHAGIC CYSTITIS 2
SS OEDEMA MANTLE CELL LYMPHOMA 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ANAEMIA 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE BONE MARROW FAILURE 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE DISEASE RECURRENCE 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE FEBRILE NEUTROPENIA 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE HERPES ZOSTER DISSEMINATED 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE LUNG DISORDER 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE NEUTROPENIA 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE NEUTROPHIL COUNT DECREASED 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE RENAL FAILURE 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE THERAPEUTIC RESPONSE DECREASED 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE THROMBOCYTOPENIA 2
SS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE XANTHOGRANULOMA 2
SS TOXOPLASMOSIS DRUG ERUPTION 1
SS WALDENSTROM'S MACROGLOBULINAEMIA BRONCHOPULMONARY ASPERGILLOSIS 12
SS WALDENSTROM'S MACROGLOBULINAEMIA EYE INFECTION TOXOPLASMAL 12
SS WALDENSTROM'S MACROGLOBULINAEMIA HERPES ZOSTER 12
SS WALDENSTROM'S MACROGLOBULINAEMIA LEUKOENCEPHALOPATHY 6
SS WALDENSTROM'S MACROGLOBULINAEMIA MYELODYSPLASTIC SYNDROME 12
SS WALDENSTROM'S MACROGLOBULINAEMIA PNEUMONIA 12
SS WALDENSTROM'S MACROGLOBULINAEMIA PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6
SS XANTHOGRANULOMA ANAEMIA 4
SS XANTHOGRANULOMA BONE MARROW FAILURE 4
SS XANTHOGRANULOMA DISEASE RECURRENCE 4
SS XANTHOGRANULOMA FEBRILE NEUTROPENIA 4
SS XANTHOGRANULOMA HERPES ZOSTER DISSEMINATED 4
SS XANTHOGRANULOMA LUNG DISORDER 4
SS XANTHOGRANULOMA NEUTROPENIA 4
SS XANTHOGRANULOMA NEUTROPHIL COUNT DECREASED 4
SS XANTHOGRANULOMA RENAL FAILURE 4
SS XANTHOGRANULOMA THERAPEUTIC RESPONSE DECREASED 4
SS XANTHOGRANULOMA THROMBOCYTOPENIA 4
SS XANTHOGRANULOMA XANTHOGRANULOMA 4
C COELIAC DISEASE ENCEPHALITIS 6
C COELIAC DISEASE INTESTINAL T-CELL LYMPHOMA 6
C COELIAC DISEASE MENINGITIS 2
C COELIAC DISEASE MENINGOCOCCAL SEPSIS 2
C COELIAC DISEASE SEPSIS 2
C COELIAC DISEASE STEM CELL TRANSPLANT 2
C HAEMATOPOIETIC STEM CELL MOBILISATION ENCEPHALITIS 3
C HAEMATOPOIETIC STEM CELL MOBILISATION INTESTINAL T-CELL LYMPHOMA 3
C HAEMATOPOIETIC STEM CELL MOBILISATION MENINGITIS 1
C HAEMATOPOIETIC STEM CELL MOBILISATION MENINGOCOCCAL SEPSIS 1
C HAEMATOPOIETIC STEM CELL MOBILISATION SEPSIS 1
C HAEMATOPOIETIC STEM CELL MOBILISATION STEM CELL TRANSPLANT 1
C HAIRY CELL LEUKAEMIA ACUTE RESPIRATORY DISTRESS SYNDROME 1
C HAIRY CELL LEUKAEMIA CYTOMEGALOVIRUS INFECTION 1
C HAIRY CELL LEUKAEMIA DRUG ERUPTION 2
C HAIRY CELL LEUKAEMIA DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
C HAIRY CELL LEUKAEMIA FEBRILE NEUTROPENIA 1
C HAIRY CELL LEUKAEMIA GASTROINTESTINAL HAEMORRHAGE 1
C HAIRY CELL LEUKAEMIA LIVER FUNCTION TEST ABNORMAL 2
C HAIRY CELL LEUKAEMIA LUNG INFILTRATION 1
C HAIRY CELL LEUKAEMIA NEUTROPHIL COUNT DECREASED 1
C HAIRY CELL LEUKAEMIA PANCYTOPENIA 1
C HAIRY CELL LEUKAEMIA PLEURAL EFFUSION 1
C HAIRY CELL LEUKAEMIA PNEUMONIA 1
C HAIRY CELL LEUKAEMIA PYREXIA 1
C HAIRY CELL LEUKAEMIA RASH ERYTHEMATOUS 2
C HAIRY CELL LEUKAEMIA RASH PUSTULAR 2
C HAIRY CELL LEUKAEMIA RASH VESICULAR 2
C NEUTROPENIA ACUTE RESPIRATORY DISTRESS SYNDROME 1
C NEUTROPENIA LUNG INFILTRATION 1
C NEUTROPENIA NEUTROPHIL COUNT DECREASED 1
C NEUTROPENIA PLEURAL EFFUSION 1
C NEUTROPENIA PYREXIA 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG ERUPTION 10
C PRODUCT USED FOR UNKNOWN INDICATION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10
C PRODUCT USED FOR UNKNOWN INDICATION LIVER FUNCTION TEST ABNORMAL 10
C PRODUCT USED FOR UNKNOWN INDICATION RASH ERYTHEMATOUS 10
C PRODUCT USED FOR UNKNOWN INDICATION RASH PUSTULAR 10
C PRODUCT USED FOR UNKNOWN INDICATION RASH VESICULAR 10
C TOXOPLASMOSIS DRUG ERUPTION 2
C TOXOPLASMOSIS DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2
C TOXOPLASMOSIS LIVER FUNCTION TEST ABNORMAL 2
C TOXOPLASMOSIS RASH ERYTHEMATOUS 2
C TOXOPLASMOSIS RASH PUSTULAR 2
C TOXOPLASMOSIS RASH VESICULAR 2
Ads by Google